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  1Application of Biotechnology in Agriculture and Medicine: United 




Discrepancies in the attitude between US and UK consumers toward application of 
biotechnology in crop production and medicine were examined using data from mail and 
online surveys. Results showed that more than 31% (46%) of US (UK) respondents were 
opposed to biotech foods while only 16% (18%) opposed biotech medicine, respectively. 
Perceived risks and benefits of agro-biotechnology and medical biotechnology were 
significant in determining overall attitude toward application of biotechnology in 
agriculture and medicine i.e., perceived risks (benefits) caused consumers to oppose 
(support) application of biotechnology in food production and medicine.  
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Application of biotechnology in agriculture and medicine has produced a growing 
number of organisms and products. Along with the increasing commercial success of 
application of biotechnology, a widespread debate focusing on the ecological, human 
health and socio-economic effects of biotechnology is taking place at national and 
international levels. There is a remarkable disparity in the level of support to applications 
of biotechnology between the United States and European countries. While more than 70 
percent of US consumers surveyed in 1992, 1995, and 1998 supported the application of 
biotechnology in food production (Moon and Balasubramanian, 2001; Hoban,1998),  
European consumers have voiced intense health and environmental concerns about foods 
containing genetically modified (GM) organisms (Zechendorf, 1998; Gaskell et al., 
1999). Although a majority of the Europeans are opposed to the idea of applying 
biotechnology in food production, they are increasingly supportive of the use of 
biotechnology in the field of medicine.  A study to capture attitudes of Swedes to 
marginal donors and xenotransplantation confirmed increased acceptance of use of 
biotechnology for specific medical purposes (Lundin and Idvall, 2003). Such cautious 
support to medical biotechnology is found across the polls in the United States and 
Europe (Singer and Lamias, 1998; Priest, 2000). Several studies have addressed 
consumers concerns regarding agro-biotechnology and medical biotechnology by 
measuring consumer willingness-to-pay for nonGM food products using contingent 
valuation or nonhypothetical lab experiments (Lusk et al, 2001, Huffman et al., 2001; 
Moon and Balasubramanian, 2003).  They showed that some segment of the US 
  3population were willing to pay a certain size of premium to avoid GM food products.  A 
majority of literature on genetically modified (GM) food products, however, does not 
address those consumers who are indifferent to the risk of consuming GM foods. These 
consumers typically choose “don’t know” (DK) option when asked about the concerns 
regarding biotechnology. Motivation behind such selection may have been primarily lack 
of adequate knowledge of biotechnology. Wang (1997) listed a feeling of being 
inadequately informed regarding the proposed issue as a reason for DK response. There 
are several strategies adopted to address the issue of DK. Wang (1997) suggested that one 
of the ways to treat DK responses was by dropping such responses based on the 
assumption that socioeconomic and other characteristics of DK respondents were the 
same as the remaining sample. Haener and Adamocwitz (1998) demonstrated alternative 
ways of treating DK responses including dropping them and recoding them. Moon and 
Balasubramanian (2003) deleted DK responses while evaluating the attitude toward agro-
biotechnology among US consumers. It is important, however, to consider the DK 
respondents in examining the consumer attitude toward biotechnology particularly when 
the size of such response is large in relation to the sample size. 
There are several important questions relating to the application of biotechnology 
in agriculture and medicine. First is the impact of DK respondents on the overall attitude 
toward biotechnology. Second question is related to the role of risks and benefits 
perceptions, and other socio demographic attributes of consumers in forming the attitudes 
toward biotechnology. This paper offers some empirical insights into these issues using 
consumer surveys administered in December, 2000, online in the United Kingdom (2,568 
respondents) and via mail in the US (3,060 respondents). While consumer sentiments 
about biotechnology vary across countries within the European Union, the United 
  4Kingdom is most likely to represent the middle ground among its 15 member nations. For 
example, Gaskell (2000) shows that Greece, Austria, and Luxembourg belong to the 
group least supportive of agrobiotechnology (14%-30%), and the Netherlands, Spain, and 
Finland are most supportive (69%-75%). The UK is in the middle group along with 
Germany and Belgium (47%-50%). Hence, it seems reasonable to use the UK as a proxy 
for the EU (Moon and Balasubramanian, 2001). The database includes an array of 
variables measuring consumer acceptance, perceptions, and trust of regulatory agencies 
that shed light on current trends in public sentiment about biotechnology. Our study first 
examines survey results of particular relevance to addressing the questions raised above. 
Then a two-stage ordered probit regression model is developed to evaluate the 
relationship between the attitude toward agro-biotechnology and medical biotechnology,  
and an array of socio-demographic and attitudinal variables.  
 
Survey Design 
A survey instrument was designed to measure attitudes and perceptions as related 
to agro-biotechnology, and medical biotechnology.  The surveys were administered by 
mail survey in the US and online survey in the UK using household panels maintained by 
the National Panel Diary (NPD) group, a marketing consulting firm specializing research 
on consumer behavior and food marketing. Survey methods that use an established panel 
are called “permission-based surveys” and are increasingly used in exploring various 
aspects of consumer behavior for academic or commercial purposes. Questionnaires were 
distributed to 5,200 households (a subsample of NPD panel), selected across the United 
States by random sampling.  The US sample was stratified by geographic regions, head of 
household age, education, and income, consistent with the US census for adults.  The 
  5same instrument was administered to consumers in the United Kingdom using online 
methods.  Questionnaires were sent to about 9,000 participants of the online panel via 
emails, and 2,568 consumers completed the online survey within the next seven days. 
 
Results 
Public Acceptance  
Public acceptance of biotechnology in agriculture and medicine was measured 
using a six-point Likert scale ranging from "Strongly oppose" to "Strongly support." 
Unsure respondents could select the option "Don't know."  Table 1 shows the distribution 
of responses for the entire sample and also across the US and UK. While responses were 
equally split between “oppose” and “support” in case of agro-biotechnology, more 
respondents supported application of biotechnology in medicine than opposed it. Most 
notably, the percentage of US respondents that supported application of biotechnology in 
agriculture (32.4%) in our survey was considerably lower than the 70% reported by 
Hoban up to 1998. This finding corroborates the declining trend in the public acceptance 
rate in the US over the last few years (Moon and Balasubramanian, 2001). Yet the figure 
displays a key discrepancy across the US and UK. While almost half of the respondents 
opposed agro-biotechnology in UK, only about third of the respondents opposed in the 
United States. The percentage of consumers who selected "Don't know" was significantly 
larger in the US (35.5%) than UK (15.8%). This result suggests that a significant segment 
of US consumers have not developed attitudes toward application of biotechnology in 
agriculture. This result has been found elsewhere (Hoban, 1998). 
It is interesting to compare and contrast the evolution of the attitudes of 
consumers toward biotechnology in the pharmaceutical and food domains. In this study, 
  6almost 60% of the overall respondents supported application of biotechnology in 
medicine, compared to a third of the respondents in food production. Such support is 
further accentuated when analyzed across countries. Historically, public opinion in the 
US and Europe has been more positive about medical biotechnology than agricultural 
biotechnology. Our survey result mirrors this trend: 30.8% (46.4%) of US (UK) 
respondents were opposed to biotechnology for foods while only 16.2% (17.5%) opposed 
biotechnology for medicine, respectively. A   study evaluating Swedish consumers’ 
opinions about gene technology (Hursti et al., 2002) reported that respondents were more 
positive to applications of “GM bacteria for medical purposes” than in food production. 
Although both biotech foods and biotech medicine are subject to regulatory oversight by 
the FDA and the European counter parts, a plausible explanation for these differences 
stems from the extent of control mechanisms in place to enhance consumer welfare. That 
is, the field of biotech medicine has professional gatekeepers (i.e., physicians who 
command a high degree of consumer trust) that prescribe, direct, and control the 
consumption of such products to benefit consumers (Moon and Balasubramanian, 2001). 
Moreover, the dosage and regimen associated with the consumption of biotech drugs is 
tailored to the needs of the individual. Such gate-keeping or tailoring activities do not 
exist for biotech foods. Another plausible explanation that has been advanced is that 
medical applications of the technology offer tangible direct benefits to consumers 
whereas the first generation of GM foods has offered only indirect benefits. Further, due 
to lack of sufficient data many of the health and environmental questions associated with 
agricultural biotechnology are not answered conclusively.  
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Table 2 presents the distribution of responses to the seven questions dealing with 
perceived risks and benefits of application of biotechnology in various fields including 
crop production. Questions pertaining to perceived risks included health risks from 
application of biotechnology, environmental hazards, moral issues, role of multinational 
corporation as a main beneficiary of the benefits of biotechnology, and control of food 
supply by multi-national corporation as a result. The benefit perceptions included 
increase in yield, reduced use of chemical and fertilizers, and improved nutrition. 
Percentage distribution for UK sample is presented in parentheses. Mean tests were 
conducted using Tuckey procedure (SAS, 2004). Mean values with same letters indicated 
that there were not significant difference between USA and UK at 0.05 critical value.  
Overall, UK respondents showed a greater level of consensus about the perceived 
risks as well as benefits of application of biotechnology than US respondents. More US 
consumers (24.4%) reported DK about moral issues regarding the application of 
biotechnology than UK consumers (8.1%). It seems UK consumers were more certain 
about moral issues than US consumers and more of them disagreed that application of 
biotechnology was morally wrong. Also, greater percentage of UK consumers agreed that 
the application of biotechnology in crop production resulted in higher yield rate than US 
consumers; more of them also agreed that the technology was hazardous to health and 
environment. About 65% of UK respondents were concerned about adverse 
environmental effects resulting from agro-biotechnology. The beneficiaries of 
biotechnology also determined the consumer acceptance of biotechnology.  If there were 
only commercial interests but no obvious benefits to the consumers the acceptability is 
low among the European consumers (Moon and Balasubramanian, 2001; Grov-White et 
  8al., 1997). In this study,  71% of UK respondents perceived multinational corporations as 
being the primary beneficiaries of biotechnology with consumers assuming most of the 
risks. Multinational corporations were seen increasingly to control farming. There was 
also a divergence in the percentage of respondents across the US and UK who selected 
DK: the US consumers were much more predisposed to choose the DK option than UK 
consumers across all questions (25%-50% in the US vs. 8%-28% in the UK).  
 
A regression analysis to evaluate the factors influencing the attitude toward application 
of biotechnology in crop production and medicine 
  A regression analysis is conducted to provide detailed analysis of the relationship 
between various behavioral and socio-economic factors, and attitude toward the 
application of biotechnology in crop production and medicine. A shown in Table 1, 13 to 
35% of the respondents have reported DK responses. Due to the presence of such high 
DK responses, the empirical model is developed using a two-stage framework. In the first 
stage, respondents who reported, DK to the questions regarding their attitude toward 
biotechnology in crop production and medicine were compared with those with definite 
opinion about biotechnology. One alternative to treat the DK responses is to drop the DK 
responses based on the assumption that socio-demographic and other personal 
characteristics of such respondents are the same as the rest of the respondents (Wang, 
1997).  Such deletion is effectively censors the data causing results to be bias (Long, 
1989). One approach to estimating regression with censored data was proposed by 
Heckman (1976) using a two-stage estimator in which one of the parameters is estimated 
in the first stage and used in correcting the biasness of the results. Following this 
approach, the relationship between explanatory variables and the dependent binary 
  9variable representing DK or otherwise responses to attitude question is analyzed.  This is 
done using a binary Probit model.  
In the second stage, only those respondents who chose one of the six answers 
ranging from strongly oppose to strongly support the application of biotechnology in crop 
production and medicine were included. At this stage, an ordered probit regression model 
was selected as the appropriate empirical model given that the attitude variable was 
measured using a scale that allowed for the ranking of the outcomes. Ordered probit 
models have been widely used in agricultural economics, particularly to study consumer 
preferences for foods (e.g., Misra, Huang, and Ott, 1991; Huang, Kan and Fu, 1999; Fu, 
Liu and Hamint, 1999).    The empirical model was defined as 
( 1 )       Y * t=$NXt + ,t
where  Y*t is an unobserved attitude toward application of biotechnology and medicine; 
Xt is a vector of variables (Table 3) including socio-demographic attributes of the 
respondents hypothesized to affect the attitude toward agricultural and medical 
application of biotechnology; $ is the vector of unknown parameters and ,t is the 
independently and identically normally distributed error term. While Y*t is unobserved, 
respondents actually report acceptance of application of biotechnology in agriculture or 
medicine by selecting one of the six categories (Yt) representing consumers’ support and 
opposition to biotechnology.  Values for Yt are 1,2,3,4,5 and 6 where 1 represents 
strongly oppose (SO) to the statement “Please indicate your attitude about the use of 
biotechnology in crop production” and “Please indicate your attitude about the use of 
biotechnology in medicine” and 6 represents strongly support (SS). The unknown 
parameter vector, $,  in equation (1) were estimated using LIMDEP (7) software.  
 
  10Independent Variables: 
The first group of independent variables included consumers’ general food related 
attitude and purchase behavior. Attitude toward application of biotechnology in 
agriculture may be reflected in consumers’ general food related attitude and purchase 
behavior. In this section, consumers were asked questions relating to their perception 
about the safety of food supply and the influence of food prices and food safety in their 
food purchase decisions.  These variables were expected to be associated with attitude 
toward application of biotechnology in food production only. Attitude toward the 
government role in safety of the food supply (FOOD_SUPPLY), importance of food 
safety (FOOD_SAFETY), price (FOOD_PRICE) in food purchasing decisions, and 
consumption frequency of organic food products (FOOD_ORGANIC).  Consumers who 
are risk averse are likely to be more concerned about safety of food, hence generally have 
less favorable attitude toward application of biotechnology.  One of the promises of agro-
biotechnology is higher yield rates and increased food supply resulting in lower prices of 
food in general.   The importance of price (FOOD_PRICE) in food shopping is 
anticipated to impact attitude toward agro-biotechnology positively. The consumption 
frequency of organic food products (FOOD_ORGANIC) is expected to be negatively 
related to attitude toward agro-biotechnology.  
A high correlations (ranging from 0.54 to 0.76) among consumer perceptions 
about the perceived drawbacks of biotechnology found, implying that it would be 
difficult to isolate the impact of each negative factor on the attitude toward application of 
biotechnology in food production and medicine.   To cope with potential 
multicollenearity problems in estimating the empirical models, an index of perceived 
risks (RISKS) was constructed by adding consumer responses to the five questions 
  11describing the negative attributes.  Theoretically, the index could range from 5 
(representing complete disagreement with the negative aspects of agrobiotechnology) to 
30 (representing complete agreement).  Similarly, a benefit index (BENEFIT) was 
created using consumer responses to positive attributes.  The benefit index could range 
from 3 (representing complete disagreement with the positive aspects of the application 
biotechnology in food production and medicine) to 18 (representing complete 
agreement). It is anticipated that perceived risks of biotechnology will have negative 
impact of the attitude. Consumers who strongly agreed that applications of biotechnology 
have many negative attributes would tend to oppose such application in food production 
and medicine.  
Consumers’ level of awareness about biotechnology was measured by asking how 
much have they read or heard about GMOs (HEAR_GM).  As discussed above, a 
generally positive attitude of US consumers toward agro-biotechnology along with high 
percentage of “don’t know” responses may have been the artifact of less knowledge 
about biotechnology compared to the European consumers. On the other hand, European 
consumers were more positive toward application of biotechnology in medicine due to a 
greater level of awareness. Therefore a positive association between level of awareness 
and attitude toward application of biotechnology in medicine is expected. The results for 
agro-biotechnology, however, are expected to be just the opposite. Consumers’ concern 
of health hazard  (HEALTH_GM) due to GM food demonstrates that consumers are 
generally averse to the idea application of biotechnology. Hence, those who have a higher 
level of concern are expected to have negative attitude towards the application of 
biotechnology in food production and medicine.  
 
  12Prior literature suggests that demographic characteristics affect consumer’ 
perceptions and attitudes about biotechnology. Surveys show that the level of education 
and gender makes a significant difference in explaining public acceptance of biotech 
foods: males and respondents with higher education were more likely to accept biotech 
foods (Alger, 2002; Nature of Science, 2000).  Heiman, Just, and Zilberman (2000) also 
showed that education had a significant role in explaining Israel consumers’ attitudes 
toward biotech foods.  Hence, gender, age, income, and education were considered in this 
study. Impact of education is measured using two variables: those with college education 
and those with science degree in college.  
Regression Models: 
Two separate regression models with three data sets were estimated. The first 
regression equation evaluated the consumer attitude towards agro-biotechnology. Models 
were estimated using ALL sample, USA sample, and UK sample. Similarly, the second 
equation evaluated the attitude toward medical biotechnology using three sample sets. 
The regression models were specified as follows:  
Model 1: Two-stage model to evaluate attitude towards agro-biotechnology 
First Stage: 
DK (=0) or otherwise responses to attitude toward agro-biotechnology (=1) = N + 
(1FOOD_SUPPLY + (2FOOD_SAFETY + (3FOOD_PRICE + (4FOOD_ORGANIC + 
(5HEAR_GM + (6HEALTH_GM + (7RISKS + (8BENEFITS + (8GENDER + (9AGE 
+ (10INCOME + (11COLLEGE + (12SCIENCE  + ε1  
Second Stage: 
Attitude toward application of biotechnology in Food Production  (0,1,2,3,4,5)  = α + 
$1FOOD_SUPPLY + $2FOOD_SAFETY + $3FOOD_PRICE + $4FOOD_ORGANIC + 
  13$5HEAR_GM + $6HEALTH_GM + $7RISKS + $8BENEFITS + $8GENDER + $9AGE 
+ $10INCOME + $11COLLEGE + $12SCIENCE  + ε2  
Model 2: Two-stage model to evaluate attitude towards medical biotechnology 
First Stage: 
DK (=0) or otherwise responses to attitude toward medical biotechnology (=1) = H + 
D1HEAR_GM + D2HEALTH_GM + D3RISKS + D4BENEFITS + D5GENDER + D5AGE + 
D6INCOME + D7COLLEGE + D8SCIENCE  + δ1  
Second Stage: 
Attitude toward medical biotechnology (0,1,2,3,4,5) = R + F1HEAR_GM + 
F2HEALTH_GM + F3RISKS + F4BENEFITS + F5GENDER + F5AGE + F6INCOME + 
F7COLLEGE + F8SCIENCE  + δ2  
Regression Results 
In the first stage, respondents who reported DK were compared with those with a 
definite attitude. In the second stage, only those respondents with specific opinion 
expressed using the six-point scale were selected. Maximum likelihood estimates were 
reported only for the second stage results (Table 4 and 5). A simulation analysis was 
conducted to further analyze the effect of risk and benefit perception on the attitude 
toward the application of biotechnology in agriculture and medicine. Models were 
estimated using all sample (AS), US sample (US), and UK sample (UK). A likelihood 
ratio test rejected the hypotheses that US consumers’ attitude toward agro-biotechnology 
was not different from that of UK consumers. The calculated chi-square value was 45.8 
compared to the critical value of 34.1 (d.f.=18) at " = 0.01. The chi-square value to test 
the similarity among US and UK consumers in relation to medical biotechnology was 
32.92 compared to the critical value of 29.14 (d.f.=14) at " = 0.01.  Therefore, the 
  14hypothesis that US and UK consumers were identical in terms of their attitude toward 
medical biotechnology was also rejected. 
 
Consumers’ Food Related Behavior and their attitude toward Agro-
Biotechnology 
 
Consumers who expressed trust in public authorities in ensuring safety in food 
supply (FOOD_SUPPLY) tend to have more positive view of application of 
biotechnology in food production than those who generally mistrusted government 
authorities (βAS=0.0798; P-value<0.0001). In this study, the impact of trust was more 
substantial in US than in UK (βUS=0.0921; βUK=0.0554), which is highly relevant to 
current public debates on bovine spongiform encephalopathy (BSE). UK consumers 
generally have less trust in their government organizations compared to the US 
consumers (Moon and Balasubramanian, 2001). On average, more Europeans preferred 
international organizations such as United Nations and the World Health Organization to 
their own national or pan-European public bodies (Nature, 1997). Trend are increasing 
lack of confidence in national political institutions. The generally higher level of trust 
among American consumers has allowed authorities to manage the BSE situation in USA 
without any kind of public backlash compared to that in Europe. 
Consumers’ attitudes toward the agro-biotechnology were shaped by the 
perceived importance of food safety (βAS=0.0425; P-value=0.0038) and food prices 
(βAS=0.0423; P-value=0.0038) in food purchase decision-making. Among all consumers, 
food safety seemed to be as important as food prices. Consumers who were concerned 
about food safety were less likely to have a positive attitude toward agro-biotechnology. 
US and UK consumers differed in terms of the role of food safety in shaping their attitude 
  15toward agro-biotechnology. UK consumers (βUK=-0.0536; P-value=0.0068) valued food 
safety more than US consumers (βUS=-0.0226; P-value=0.3245).  
The most highlighted attribute of agro-biotechnology is its ability to increase 
yield rates, thus increase the agricultural production. The direct impact of such enhanced 
supply would be on food prices. Therefore, it is consistent that consumers who associate 
biotechnology as a means to lower food price are supportive of agro-biotechnology. Food 
prices were more important to US consumers ( than their UK counterparts.  
A statistically significant association between frequency of organic food purchase 
and attitude toward agro-biotechnology is found among UK consumers. Those who were 
purchasing organic food more frequently were likely to oppose agro-biotechnology than 
who seldom purchased organic food.  
 
Risk and Benefit Perception and Attitude toward Application of Biotechnology in 
Agriculture and Medicine 
 
Perceived risks and benefits of application of biotechnology as represented by 
RISK and BENEFIT were highly significant in determining overall attitude toward 
application of biotechnology in agriculture and medicine i.e., perceived negative 
(positive) attributes caused consumers to oppose (support) application of biotechnology 
in food production and medicine. Perception of benefits had more impact on the 
likelihood of “strongly opposing” the applications of biotechnology than the perception 
of risks. The effects of risk and benefit perception on consumer attitude were simulated 
using the estimated parameters and a range of index values (Figure 1 to 4).  The 
perception of benefits reduced the probability of “strongly opposing” the application of 
biotechnology in medicine by a little more than 40% (30%) among US (UK) consumers 
  16within the range of possible index values. Similar percentage for agro-biotechnology was 
20% (7%). Hence, the disparity was much more evident in the results for medical 
biotechnology than for agro-biotechnology. Perceived benefits were more powerful in 
alleviating negative attitude than perceived risks in shaping the negative attitude toward 
the applications of biotechnology. The results were similar but more accentuated among 
US consumers compared to UK consumers.  This has an important implication in policy 
making.  Generally policy debates regarding biotechnology are focused more on potential 
risks to environment and /or human health. If, however, people are more swayed by 
potential benefits, then focus needs to be shifted to potential benefits. 
Effect of Consumer Awareness and Concern 
Consumers who have heard or read about biotechnology were likely to support 
applications of biotechnology than those who have a lower level of awareness about the 
issues. The strength of the impact was considerably larger compared to RISKS and 
BENEFITS across all samples.  Moreover, the marginal effect of awareness on the 
likelihood of “strongly opposing” applications of biotechnology was highest among the 
US consumers. It implies that greater dissemination of information with particular 
emphasis on the positive attributes is likely to generate more support from the American 
consumers than the European consumers.  
Gender and science degree were statistically significant among all the samples 
and for both ago-biotechnology and medical biotechnology models. Females were 
substantially more unfavorable about the applications of biotechnology than males. 
Consumers with science degree in college were more likely to favor the applications of 
biotechnology than those without science degree. Socio-demographic variables seemed to 
interact with purchase behavior variables resulting in a number of socio-demographic 
  17variables to be statistically insignificant. When purchase behavior variables were 
excluded in the model dealing with medical biotechnology, the results show that almost 
all socio-demographic variables were significant in shaping attitudes. For example, 
higher income consumers were likely to support application of biotechnology in medicine 
than the lower income consumers. The impact of income is much more larger in UK 
(B=0.0024) than in USA (B=0.0020). Older consumers were less supportive of the 




Discrepancies in the attitude between US and UK consumers toward application 
of biotechnology in crop production and medicine were examined using data from mail 
and online surveys. Preliminary results showed that more than 31% (46%) of US (UK) 
respondents were opposed to biotech foods while only 16% (18%) opposed biotech 
medicine, respectively. Perceived risks and benefits of agro-biotechnology and medical 
biotechnology were significant in determining overall attitude toward application of 
biotechnology in agriculture and medicine i.e., perceived risks (benefits) caused 
consumers to oppose (support) application of biotechnology in food production and 
medicine. Consumers who have heard or read about biotechnology were likely to support 
applications of biotechnology than those who have a lower level of awareness about the 
issues.   
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Table 1: Distribution of consumer responses to attitude toward application of 
biotechnology in Agriculture and Medicine 
 
All Sample 
United States  
(United Kingdom) 
  Oppose Support
Don’t 
Know  Oppose Support
Don’t 
Know 
Attitude about the use of biotechnology in 
crop production 












Attitude about the use of biotechnology in 
medicine 












Note. Six-point scale ranging from "Strongly Oppose" to "Strongly Support" was used. In the table "Oppose " is an aggregation of the 
first three categories while "Support" is for the last three categories. The numbers in the parenthesis are for United Kingdom.  Mean 
tests were conducted using Tukey process. Means with the same letters are not significantly different at 5%. 
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Table 2. Perceived  risks and benefits of application of biotechnology.
1
All Sample 
United States  
(United Kingdom) 
  Disagree Agree
Don't 
Know Disagree  Agree  Don't Know
Risks (%) 












































































































1Six-point scale ranging from "Disagree completely" to "Agree completely" was used. In the table "Disagree" is an aggregation of the 
first three categories while "Agree" is for the last three categories.  
a Respondents responded to the following statement, "Corporations are the main beneficiaries from agricultural biotechnology, while 
consumers assume most of the risk." 
b Respondents responded to the following statement, "The development and use of genetically modified seeds will negatively impact 
family farms by putting more control of the food supply into the hands of multinational corporations."  
The numbers in the parenthesis are for United Kingdom.  Mean tests were conducted using Tukey process. Means with the same 
letters are not significantly different at 5%. 
  22Table 3: Descriptive statistics of the variables used in the regression analysis. 
 
Mean  Variable  Explanation 
ALL  USA  UK 
AGBIO  Attitude about the use of biotechnology  




MEDBIO  Attitude about the use of biotechnology  




General Food Related Attitude and Purchase Behavior:      
FOOD_SUPPLY  The government ensures safety of the food supply 




FOOD_SAFETY  Safety is an important consideration in food purchasing 




FOOD_PRICE  Price is an important consideration in food purchasing 









Awareness about GM and Concern among the respondents:      
HEAR_GM  How much heard about genetically modified organism 




HEALTH_GM  Likelihood of health hazard from eating GM 




Index of perceived risks and benefits of application of bio-technology:      
RISKS  Index of perceived risks of applications of biotechnology  




BENEFITS  Index of perceived benefits of applications of 




Demographic Characteristics of the Respondents:      
GENDER  Female =1; Male=0  0.50  0.53
 A 0.45
 B
AGE  Age of the respondents  40.31 45.48
 A 34.26
 B
INCOME  Household income in ‘000 dollars  12.43 17.88
 A 5.94
B
COLLEGE  1=college education; 0 otherwise  0.36  0.47
A 0.23
B
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Table 4: Attitude toward agro-biotechnology: Maximum Likelihood Estimates of 
Ordered Probit Model corrected for sample selection bias caused by “Don’t know” 
responses  
 





P-Value  Estimated 
Parameter 
(βUS) 




Constant 2.4484*  0.0000 1.7941*  0.0000 3.3060*  0.0000 
FOOD_SUPPLY 0.0798*  0.0000 0.0921*  0.0001 0.0554*  0.0068 
FOOD_SAFETY -0.0425*  0.0038 -0.0226  0.3245 -0.0536*  0.0072 
FOOD_PRICE 0.0423*  0.0038 0.0382* 0.0791 0.0308  0.1291 
FOOD_ORGANIC -0.0112 0.4071 0.0308  0.1146 -0.0575*  0.0035 
HEAR_GM 0.1277*  0.0000 0.1394*  0.0000 0.1197*  0.0000 
HEALTH_GM -0.1771*  0.0000 -0.1684* 0.0000 -0.1950*  0.0000 
BENEFITS 0.1419*  0.0000 0.1526*  0.0000 0.1300*  0.0000 
RISKS -0.1172*  0.0000 -0.1075*  0.0000 -0.1274*  0.0000 
GENDER -0.1342*  0.0001 -0.1516*  0.0030 -0.1244*  0.0167 
AGE -0.0008  0.5547 -0.0016  0.4516 -0.0015  0.5261 
INCOME 0.0005  0.2243 0.0008  0.1824 0.0002  0.7598 
COLLEGE -0.0151  0.6937 -0.0033  0.9511 -0.0270  0.6397 
SCIENCE 0.1809*  0.0001 0.1398*  0.0629 0.2205*  0.0002 
Threshold 
parameters for 
Index       
Mu( 1)  0.9032*  0.0000 0.8662*  0.0000 0.9470*  0.0000 
Mu( 2)  1.8242*  0.0000 1.7423*  0.0000 1.9229*  0.0000 
Mu( 3)  3.0860*  0.0000 2.9301*  0.0000 3.2770*  0.0000 
Mu( 4)  4.2906*  0.0000 4.0455*  0.0000 4.6183*  0.0000 
Log  likelihood -5067.97   -2482.42   -2562.65  
Chi-squared  2182.47   1502.69  668.91  
*Significant at " <10% 
  24Table 5: Attitude toward Medical biotechnology: Maximum Likelihood Estimates of 
Ordered Probit Model corrected for sample selection bias caused by “Don’t know” 
responses  
 





P-value  Estimated 
Parameter 
(FUS) 




Constant  2.3989* 0.0000 2.1770*  0.0000 2.6686*  0.0000 
HEAR_GM  0.1489* 0.0000 0.1577*  0.0000 0.1321*  0.0000 
HEALTH_GM  -0.1627* 0.0000 -0.1383*  0.0000 -0.1876*  0.0000 
REGULATION  0.0074 0.5858 -0.0058  0.7689 0.0259  0.2152 
BENEFITS  0.0880* 0.0000 0.0998*  0.0000 0.0768*  0.0000 
RISKS  -0.0534* 0.0000 -0.0527*  0.0000 -0.0546*  0.0000 
GENDER  -0.1847* 0.0000 -0.1677*  0.0009 -0.1805*  0.0002 
AGE  -0.0061* 0.0000 -0.0070*  0.0008 -0.0048*  0.0217 
INCOME  0.0023* 0.0000 0.0020*  0.0050 0.0024*  0.0001 
COLLEGE  -0.1958* 0.0000 -0.2734*  0.0000  -0.0809 0.1681 
SCIENCE  0.1970* 0.0000  0.0790  0.3301 0.2954*  0.0000 
Threshold 
parameters for 
Index          
Mu(  1)  0.4836* 0.0000 0.4557*  0.0000 0.5272*  0.0000 
Mu(  2)  1.0842* 0.0000 1.0371*  0.0000 1.1558*  0.0000 
Mu(  3)  2.0032* 0.0000 1.8934*  0.0000 2.1401*  0.0000 
Mu(  4)  2.9316* 0.0000 2.7902*  0.0000 3.1012*  0.0000 
Log  likelihood  -5855.27  -2856.91   -2981.90   
Chi-squared  1991.11  1389.70    580.25  

































































Figure 1: Simulated effect of risk perception on the probability of “Strongly Opposing” 




















































Figure 2: Simulated effect of risk perception on the probability of “Strongly Opposing” 
application of biotechnology on agriculture and medicine among UK consumers  
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